Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Journal of Cardiothoracic Surgery|July 17, 2026
Impact of revascularization strategies versus optimized medical treatment on coronary events related only to revascularized arteries: a target clinical trial emulation approachThiago Hueb, Edimar Alcides Bocchi, Paulo Cury Rezende, et al.
Frontiers in Immunology|December 6, 2021
Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy PatientsPriscila Camillo Teixeira, Axel Ducret, Hanno Langen, et al.
Plos Neglected Tropical Diseases|April 23, 2025
Left ventricular reverse remodeling: A predictor of survival in chagasic cardiomyopathy patients with a reduced ejection fractionMaria Tereza Sampaio de Sousa Lira, Silas Ramos Furquim, Daniel Catto de Marchi, et al.
ESC Heart Failure|February 10, 2025
Predictors of sustained reverse remodelling in patients with heart failure with reduced ejection fractionSilas Ramos Furquim, Edimar Alcides Bocchi, Maria Tereza Sampaio de Sousa Lira, et al.
European Journal of Heart Failure|October 27, 2012
Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot studyGermano Emílio Conceição-Souza, Paulo Manuel Pêgo-Fernandes, Fatima das Dores Cruz, et al.
American Journal of Medical Genetics. Part A|October 29, 2021
Cardiovascular findings in Williams-Beuren Syndrome: Experience of a single center with 127 casesRachel Sayuri Honjo, Vanessa Figueiredo Monteleone, Vera Demarchi Aiello, et al.
Plos Neglected Tropical Diseases|December 18, 2023
Assessment of biomarkers and clinical parameters as predictors of survival in patients with chagasic heart failureEdimar Alcides Bocchi, Guilherme Veiga Guimarães, Cristhian Espinoza Romero, et al.
Arquivos Brasileiros De Cardiologia|July 27, 2011
I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summaryJadelson Pinheiro de Andrade, Jose Antonio Marin Neto, Angelo Amato Vincenzo de Paola, et al.
JACC. Heart Failure|August 7, 2024
Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF TrialEdimar Alcides Bocchi, Luis E Echeverria, Caroline Demacq, et al.
Trials|April 18, 2020
Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF)Paulo Cury Rezende, Whady Hueb, Edimar Alcides Bocchi, et al.
Pageof 16